11/4/2022 0 Comments Cvs timingGarcia: Yes, so most of the 25 million doses that have been sent out have been the Pfizer booster. What's going on there and when will that be resolved? Unger: Well, it's interesting because there have been reports now of shortages of the Moderna booster vaccine. And, of course, the government has said it's ordered more than 170 million updated vaccine booster doses for the fall and last week it had sent out over 25 million doses. Under this new authorization, Pfizer's vaccine would become available for those aged 5 to 11 and Moderna's for those aged 6 to 17 years. Moderna's is available for those 18 and older. Just as a current reminder, Pfizer's vaccine is currently available for those 12 and older. And that document indicates that if the vaccines are authorized by the FDA, then CDC anticipates a recommendation for bivalent vaccines as a booster for that pediatric age group in early to mid-October. And this information is based on the CDC small vaccination operation planning guide, which was released last Tuesday. Garcia: Well, it's being reported that the CDC expects the updated bivalent COVID booster doses to be available for children 5 to 11-years-old by mid-October. Now we have word on the availability of boosters for kids under 12. We've had boosters available for those 12 years and older for a few weeks now. Unger: Well, let's get right into the Omicron situation. I'm Todd Unger, AMA's chief experience officer also in Chicago. Today we have our weekly look at the headlines with AMA's Vice President of Science, Medicine and Public Health Andrea Garcia in Chicago. Cvs timing update#Unger: Hello and welcome to the AMA Update video and podcast, an ongoing series covering a range of health care topics affecting the lives of physicians and patients.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |